Friday, May 3, 2024

Tag: war profiteering

Breaking the chain: Tlaib’s crusade against congressional war profiteering

This move comes amidst escalating scrutiny over the potential conflicts of interest posed by lawmakers' investments in companies that profit from military engagements.

The profiteers of war: Companies fueling the Israeli assault on Gaza

Unveiling the corporate gears of war: A comprehensive look at the companies behind Israel's devastating military campaign in Gaza.

Sanders introduces legislation to impose a 95 percent windfall tax on...

"The time has come for Congress to work for working families and demand that large, profitable corporations make a little bit less money and pay their fair share of taxes.”

Congress needs to end war profiteering now

War is bad for nearly everyone. But as long as we allow the leaders of our privatized war economy to reap unlimited rewards, their profit motive for war in Iran — or anywhere — will persist.

POPULAR

Fossil fuel tax could unlock $720 billion for climate crisis, new report finds

The Climate Damages Tax aims to rectify historical injustices and provide a tangible pathway towards a more sustainable and just world.

EPA proposes ban on pesticide widely used on fruits and vegetables

In calling for an end to all uses of the pesticide on food, the agency cited evidence that acephate harms workers who apply the chemical as well as the general public and young children.

New report finds Tyson Foods dumped pollutants into US waterways for years

The wastewater analyzed consisted of pathogens and microorganisms and slaughterhouse byproducts, such as body parts of animals, feces and blood.

Bernie Sanders speaks out: Criticizing Israeli policy is not antisemitism

Amid national debate over Gaza protests, Senator Bernie Sanders challenges the narrative equating criticism of Israel with antisemitism, drawing on his personal history and widespread American discontent.

FTC challenges Big Pharma over unfair patents as Sanders applauds regulatory crackdown

The Federal Trade Commission intensifies its fight against pharmaceutical patent abuses, aiming to slash drug prices and increase access to generic medications.